Comerica Bank Grows Stock Position in Astera Labs, Inc. $ALAB

Key Points

• Comerica Bank significantly increased its stake in Astera Labs by 887.9% in Q1, acquiring a total of 157,229 shares valued at approximately $9.38 million.
• Astera Labs reported a quarterly earnings per share of $0.44, surpassing analyst estimates and reflecting a 149.5% year-over-year revenue increase.
• Institutional investors own 60.47% of Astera Labs, with other notable increases in holdings from firms like Driehaus Capital and Bank of Nova Scotia in recent quarters.

Comerica Bank grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 887.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 157,229 shares of the company's stock after acquiring an additional 141,313 shares during the quarter. Comerica Bank owned 0.10% of Astera Labs worth $9,382,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Astera Labs by 2,824.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock worth $20,467,000 after buying an additional 149,240 shares during the period. Aigen Investment Management LP increased its stake in shares of Astera Labs by 50.9% in the first quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock worth $1,069,000 after buying an additional 6,045 shares during the period. Pacific Point Advisors LLC increased its stake in shares of Astera Labs by 75.0% in the first quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company's stock worth $418,000 after buying an additional 3,000 shares during the period. Oppenheimer Asset Management Inc. increased its stake in shares of Astera Labs by 73.6% in the first quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company's stock worth $954,000 after buying an additional 6,783 shares during the period. Finally, Taylor Frigon Capital Management LLC purchased a new position in shares of Astera Labs in the first quarter worth $1,887,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 100,000 shares of the company's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $171.38, for a total transaction of $17,138,000.00. Following the transaction, the chief financial officer owned 518,996 shares in the company, valued at approximately $88,945,534.48. This represents a 16.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jitendra Mohan sold 152,517 shares of the company's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the transaction, the chief executive officer owned 450,001 shares in the company, valued at $76,648,670.33. This represents a 25.31% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,728,116 shares of company stock worth $239,272,181. Company insiders own 12.50% of the company's stock.

Analyst Ratings Changes

Several research analysts recently commented on the stock. William Blair assumed coverage on shares of Astera Labs in a research note on Thursday, May 22nd. They issued an "outperform" rating on the stock. Needham & Company LLC boosted their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Zacks Research raised shares of Astera Labs to a "strong-buy" rating in a research report on Tuesday, August 12th. CICC Research initiated coverage on shares of Astera Labs in a research report on Friday. They set an "outperform" rating and a $190.00 price objective on the stock. Finally, Susquehanna boosted their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $135.75.

Astera Labs Price Performance

Astera Labs stock traded down $6.95 during mid-day trading on Friday, reaching $182.20. The stock had a trading volume of 3,744,678 shares, compared to its average volume of 4,930,260. The company has a market capitalization of $30.29 billion, a price-to-earnings ratio of 325.36, a PEG ratio of 4.54 and a beta of 1.39. The company has a 50-day moving average price of $130.65 and a two-hundred day moving average price of $95.03. Astera Labs, Inc. has a one year low of $36.85 and a one year high of $199.47.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business's revenue for the quarter was up 149.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.